ArticleBriefings in bioinformatics2026
MSF-HierGNN: a multi-source substructure-fusion hierarchical GNN method and web server to predict molecular property for drug design.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate prediction of the biological and physicochemical properties of molecules is of great significance in shortening the process and decreasing the failure rate of drug design. Thus, previous studies have established several benchmark datasets and developed several Graph Neural Networks (GNNs) based artificial intelligence (AI) predictive methods. However, since these methods encounter challenges such as incomplete representation of molecular hierarchical structures, insufficient exploration of local topological features, and under-extraction of correlations among atomic features, our study proposes a graph neural network that combines hierarchical pooling with localized substructure modeling named MSF-HierGNN (Multi-Source Substructure-Fusion Hierarchical Graph Neural Network) to solve these problems. Firstly, MSF-HierGNN constructs a more comprehensive and multiscale graph-level representation by preserving chemically salient structures and fusing multiple sources of substructure. Secondly, the model can more comprehensively represent molecular substructure features by integrating multiple fragmentation algorithms and incorporating five molecular fingerprints. Additionally, the model further captures correlations among atomic features by increasing the message-passing mechanism. Finally, we validate the model's effectiveness using public benchmark datasets and develop an interactive and user-friendly web server application based on MSF-HierGNN. Experiments based on benchmark datasets demonstrate that our model not only can effectively extract molecular substructure features and capture correlations among atomic features, but also can more accurately predict molecular properties, thereby offering a novel AI method and application to support drug discovery and design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.